title: Ready when you are: easing into preemptive pharmacogenetics.
abstract: The promise of pharmacogenetics has included reduction of adverse drug events and enrichment for clinical efficacy. However, there has been very little assessment of the context in which this promise could be delivered. There are issues of return on effort and end points of meaningful impact that are crucial to moving this area of clinical pharmacology into practical benefit for our health system.
authors.affiliation: UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Y J
authors.initials: YJ
authors.lastname: He
authors.forename: H L
authors.initials: HL
authors.lastname: McLeod
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions; D023381:Endpoint Determination / Q000379:methods / Q000639:trends; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends